Objective: To evaluate the effects of O-linked ␤-N-acetylglucosamine (O-GlcNAc) levels on survival, inflammation, and organ damage 24 hrs after trauma-hemorrhage. We have previously shown that increasing protein O-GlcNAc levels by different mechanisms reduced inflammatory responses and improved organ function 2 hrs after trauma-hemorrhage. Design: Prospective, randomized, controlled study. Setting: Animal research laboratory. Subjects: Male, adult Sprague-Dawley rats. Interventions: Overnight fasted animals were subjected to either sham surgery or trauma-hemorrhage and during the resuscitation phase received glucosamine (270 mg/kg) to increase O-GlcNAc synthesis or O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenyl carbamate (PUGNAc, 7 mg/kg) to inhibit O-GlcNAc removal, or mannitol as control. Measurements and Main Results: Survival was followed up for 24 hrs. Surviving rats were euthanized and inflammatory responses, and end organ injuries were assessed. Both glucosamine and PUGNAc increased 24-hr survival compared with controls (control: 53%, GN: 85%, PUGNAc: 86%, log-rank test, p < .05). PUGNAc attenuated the trauma-hemorrhage-induced increase in serum interleukin-6 (sham surgery: 8 ؎ 6, control: 181 ؎ 36, PUGNAc: 42 ؎ 22 pg/mL, p < .05), alanine transam-inase (sham surgery: 95 ؎ 14, control: 297 ؎ 56, PUGNAc: 126 ؎ 21 IU, p < .05), aspartate transaminase (sham surgery: 536 ؎ 110, control: 1661 ؎ 215, PUGNAc: 897 ؎ 155 IU, p < .05), and lactate dehydrogenase (sham surgery: 160 ؎ 18, control: 1499 ؎ 311, PUGNAc: 357 ؎ 99 IU, p < .05); however, glucosamine had no effect on these serum parameters. Furthermore, PUGNAc but not glucosamine maintained O-GlcNAc levels in liver and lung and significantly attenuated the NF-B DNA activation in the liver. In the liver and heart, increased inducible nitric oxide synthase expression was also attenuated in the PUGNActreated group. Conclusions: These results demonstrate that increasing O-GlcNAc with either glucosamine or PUGNAc improved 24-hr survival after trauma-hemorrhage. However, only PUGNAc treatment attenuated significantly the subsequent tissue injury and inflammatory responses, suggesting that inhibition of O-GlcNAc removal may represent a new therapeutic approach for the treatment of hypovolemic shock. (Crit Care Med 2010; 38: 562-571) KEY WORDS: hypovolemic shock; hexosamine biosynthesis pathway; O-GlcNAc; glucosamine; PUGNAc; multiple organ dysfunction syndrome
A cute hyperglycemia is frequently associated with injuries, such as trauma and hemorrhagic shock (1) . Stressinduced hyperglycemia has been reported to be an adaptive mechanism (2-4) and prevention of this hyperglycemic response in rats increased mortality post hemorrhage (5) . Although the precise role of stress-induced hyperglycemia remains unresolved (6) , early glycemic control improves outcome of intensive care unit patients (7) . A number of mechanisms have been proposed to account for the beneficial effects of stress-induced hyperglycemia, including fuel (2) or mobilization of interstitial fluid reserves by increasing osmolarity (3, 4) . Increased glucose levels also facilitate the flux through the hexosamine biosynthesis pathway, which has been linked to improved cell survival under stress conditions (1, 8) . One consequence of increased hexosamine biosynthesis pathway flux is increased synthesis of O-linked ␤-N-acetylglucosamine (O-GlcNAc), attached to serine and threonine residues of proteins (1, 9) .
In contrast to traditional O-glycosylation, protein O-GlcNAcylation is a rapid and reversible posttranslational modification of serine and threonine residues of nuclear and cytosolic proteins, analogous to phosphorylation (1, 8) . O-GlcNAc levels are regulated by O-GlcNAc transferase (OGT), a unique glycosyl transferase, which catalyzes the attachment of O-GlcNAc to proteins and by O-GlcNAcase, which is responsible for the removal of the moiety (1) . O-GlcNAc levels can be increased by exogenous glucosamine, which increases hexosamine biosynthesis pathway flux and increases O-GlcNAc synthesis, or by inhibition of O-GlcNAcase with PUGNAc (O-(2-acetamido-2deoxy-D-glucopyranosylidene)amino-Nphenyl carbamate) (1, 10) .
In a rat model of trauma-hemorrhage, we have shown that increasing O-GlcNAc levels improved cardiac function, tissue perfusion, and attenuated inflammatory response 2 hrs after resuscitation (11, 12) . In a model of trauma-hemorrhage with minimal resuscitation, we also demonstrated that increased O-GlcNAc formation was associated with significantly improved 2-hr survival rates (10) . These studies suggested that increased O-GlcNAcylation improves short-term outcome post trauma-hemorrhage; however, there are no reports regarding the effects of O-GlcNAcylation in mediating the longer-term responses to trauma-hemorrhage and resuscitation (TH-R). Therefore, the purpose of this study was to determine whether increasing O-GlcNAc levels with either glucosamine or PUGNAc improves 24-hr survival in rats post severe TH-R, and if so, whether this was associated with decreased organ injury and attenuation of proinflammatory responses.
MATERIALS AND METHODS
Animals. Male, adult Sprague-Dawley rats (Charles-Rivers, Wilmington, MA), weighing 260 g to 340 g, were used throughout the study. All animals were fasted overnight before surgery; however, water was available ad libitum. All animal experiments were approved by the Animal Care and Use Committee of the University of Alabama at Birmingham and conformed to the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85Y23, 1996) .
Reagents. All reagents and solutions were purchased from Thermo Fisher Scientific (Waltham, MA) or from Sigma-Aldrich (St. Louis, MO), unless indicated otherwise. PUGNAc was obtained from Toronto Research Chemicals (North York, ON, Canada).
Trauma-Hemorrhage Model. We adapted our severe, volume-controlled hemorrhagic shock model (10), a modified version of the model published by Macias et al (13) , by providing full resuscitation after blood withdrawal and 45 mins of pressure-controlled hypovolemia. Under isoflurane anesthesia (1.5% vol/vol, 1 L/min oxygen flow), two femoral arteries and the right femoral vein were cannulated for continuous blood pressure monitoring, blood withdrawal, and drug administration. A 5-cm-long midline laparotomy was performed to induce a soft tissue damage to mimic trauma before hemorrhage. All of the surgical interventions were done under aseptic conditions. Animals were kept on a heating pad with temperature set to 37°C in effort to maintain central body temperature, monitored by a rectal thermocouple. Heparin was not administered at any time during the procedures.
Hemorrhage was induced by withdrawal of 55% of the calculated total blood volume (total blood volume [mL] ϭ body weight [g] ϫ 0.061) (14) for 25 mins, using a syringe pump (Harvard Instruments, Holliston, MA). Mean arterial pressure was maintained on 35 mm Hg to 40 mm Hg for 45 mins (pressurecontrolled phase) by IV administration of small volumes of 0.9% NaCl (i.e., normal saline) solution until a maximum of 40% of the shed blood volume was returned. This was followed by resuscitation, with four times of total withdrawn blood volume of IV 0.9% NaCl, administered over 60 mins, using a syringe pump. The animals were allowed to wake up and they were observed up to 24 hrs after resuscitation, at which point surviving animals were euthanized by IV injection of concentrated KCl solution. Blood, heart, lung, and liver were collected for subsequent analyses. During the 24-hr observation period, any animals that were found to be moribund were euthanized and considered dead with respect to the survival analysis.
Experimental Groups. Animals were assigned randomly to the following four groups: 1) sham surgery; 2) control (untreated) traumahemorrhage; 3) trauma-hemorrhage with glucosamine treatment (270 mg/kg body weight); and 4) trauma-hemorrhage with PUGNAc treatment (7 mg/kg body weight). In both treatment groups, 25% of total dose in a 2-mL increment was administered immediately after hemorrhage and the remaining 75% continuously during resuscitation. These doses of glucosamine and PUGNAc have been demonstrated in previous studies to increase O-GlcNAc levels and improve short-term recovery after TH-R (11, 12) . The osmolarity of glucosamine solution used here is relatively high (ϳ300 -320 mOsm, pH adjusted to 7.36); therefore, to account for any osmolarity effects, the vehicle in both the control and PUGNAc groups included mannitol, to increase the osmolarity to that of the glucosamine solution, with a pH adjusted to 7.36. Sham surgery animals underwent only general anesthesia and vessel cannulation. All animals received 0.3 mg/kg body weight buprenorphine subcutaneously immediately following and 12 hrs after resuscitation.
Blood Gas Analysis, Serum Enzyme, Glucose, and Electrolyte Measurements. Blood gas parameters, electrolytes, glucose, and lactate levels from arterial samples were analyzed by using a blood gas analyzer (Gem Premier 3000, Instrumentation Laboratory, Lexington, MA). Serum levels of alanine transaminase, aspartate transaminase, lactate dehydrogenase, amylase, creatinine, and blood urea nitrogen were measured, using Alfa Wassermann ACE Clinical Chemistry System (Alfa Wassermann, West Caldwell, NJ) at the Animal Labs veterinary laboratory (Birmingham, AL).
Serum Cytokine Levels. Serum levels of interleukin (IL)-6 and IL-10 and tumor necrosis factor-␣ were measured with sandwich enzyme-linked immunosorbent assay kits (IL-6: Pierce Rockford, IL; IL-10 and tumor necrosis factor-␣: BioSource, Camarillo, CA), following the manufacturer's guidelines.
Immunoblots Analyses. Protein levels and O-GlcNAc levels were assessed by immunoblot analyses (10, 15) . Proteins were separated on a 7% to 10% SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) gel and transferred either to polyvinylidene difluoride (Millipore Corporation, Billerica, MA) or pure nitrocellulose membranes (Bio-Rad, Hercules, CA). Protein loading was confirmed by Sypro Ruby (Bio-Rad) staining. Membranes were incubated overnight with 1:1000 or 1:2500 dilution of CTD 110.6 (anti-O-GlcNAc), phosphoserine, phosphothreonine, GRP78 (Abcam, Cambridge, MA) or nitric oxide synthase (iNOS) (BD Transduction Laboratories, San Jose, CA). For loading control, membranes were stripped and blots were incubated with ␤-actin (Sigma-Aldrich, St. Louis, MO) or calsequestrine (Abcam) antibody. The densitometry of CTD 110.6 and phosphoserine/ threonine immunoblots were performed by selecting the whole lane (all bands) in case of each sample and measuring the mean density of selected areas after background subtraction, using Scion Image analysis software (Scion Corporation, Frederick, MD).
Nuclear Factor-B (NF-B), Apoptosis, and Myeloperoxidase (MPO) Assays. NF-B was measured with an enzyme-linked immunosorbent assay (ELISA)-based, colorimetric, oligonucleotid-binding assay (TransAM, Active-Motif, Carlsbad, CA). Apoptosis was determined using the Cell Death Detection ELISA PLUS (Roche Applied Science, Indianapolis, IN). MPO was also determined using commercially available ELISA kits (Hycult Biotechnology, Uden, Netherlands). All assays were performed, using the manufacturer's guidelines. The Cell Death Detection ELISA has been reported to be a sensitive and quantitative method and is especially suited to assess apoptosis in large numbers of samples (16) . Studies comparing histone ELISA (equivalent to Roche Cell Death ELISA) and TUNEL-staining have shown similar results from the two methods (17, 18) .
Data Analysis. Statistical analyses were performed, using GraphPad Prism 4 software (GraphPad, San Diego, CA) and SPSS13.0 (SPSS, Chicago, IL). The survival data were compared, using log-rank test, and were presented as survival percentage. Other statistical comparisons were performed, using unpaired Student's t test, correlation or parametric one-way analysis of variance with Bonferroni's or Dunnett's post hoc test, as appropriate. Data that were not normally distributed and/or of unequal variance underwent either log or rank transformations, and the analyses were performed on the transformed data with one-way or Kruskal-Wallis analyses of variances with Dunn's post hoc test, respectively.
RESULTS
Survival Rates. A total of 50 animals were subjected to the trauma-hemorrhage and full resuscitation protocol (TH-R) and observed for 24 hrs. Four animals died during either the initial surgical procedure or early during the resuscitation phase and were therefore excluded from any subsequent analyses. In contrast to less severe models of TH-R where the 24-hr survival is ϳ100% (19) , as can be seen in Figure 1 , in this model, the mortality rate for the control group was ϳ50%. The survival rate was significantly increased by both glucosamine (85%) and PUGNAc (86%) treatment. No mortality was observed in the sham surgery group (data not shown). Table 1 . Data are presented from samples collected at five time points: 1) before hemorrhage; 2) at the end of hemorrhage; 3) immediately before resuscitation; 4) at the end of resuscitation; and 5) in surviving animals, 24 hrs after resuscitation. There were no significant differences in PO 2 between groups at any time, presumably due to supplemental oxygen administered during anesthesia. Hemorrhagic shock induced hyperkalemia, hypocalcemia, and severe acidosis (Table 1) . After blood withdrawal, the acidosis was similar in all groups; however, by the end of resuscitation, it was significantly improved by both glucosamine and PUGNAc administration, compared with control animals, as indicated by increased HCO 3 Ϫ , TCO 2 , BE, and decreased serum lactate levels. At the end of the 24-hr observation period, all parameters returned to baseline levels and there were no differences between groups.
There were no significant differences in blood glucose levels in any group at the end of hemorrhage; however, blood glucose levels were significantly elevated in glucosamine group before and after resuscitation. Additionally, there were no differences in glucose levels between PUGNAc and control groups at any time point in the experiments.
Serum Cytokine Levels. Hemorrhagic shock induced a significant increase in circulating levels of proinflammatory cytokine IL-6, 24 hrs after resuscitation in the control group, which was significantly attenuated by PUGNAc, but not glucosamine ( Fig. 2A) . Compared with the sham group, the anti-inflammatory cytokine IL-10 was significantly elevated in the control group; however, IL-10 was unchanged in both glucosamine and PUGNAc groups (Fig. 2B) . Compared with the sham group, there were no significant differences in the serum levels of tumor necrosis factor-␣ in any group, 24 hrs after TH-R (data not shown).
NF-B Activation and iNOS Levels. Activation of the transcription factor NF-B was assessed by DNA-binding assay in the heart, lung, and liver. In the liver, the binding affinity of NF-B was significantly elevated in both control and glucosamine groups, 24 hrs after TH-R; however, this was significantly attenuated in the PUGNAc group (Fig. 3 ). There was no significant activation of NF-B in either heart or lung (data not shown).
In the control group, protein levels of iNOS were significantly increased compared with the sham surgery group in both liver and heart (Fig. 4A, B) . This was significantly attenuated in the PUGNActreated group, but not in the glucosamine-treated group. However, at this time point, there was no significant induction of iNOS expression in the lung (data not shown).
MPO Levels. Tissue MPO levels were significantly elevated in the control ani- Analysis of variance, a p Ͻ .05 vs. sham and b p Ͻ .05 vs. control in comparison between treatment groups and c p Ͻ .05 compared with the baseline conditions in the same group. Arterial blood samples were analyzed: before induction of hemorrhage (baseline), after hemorrhage, before resuscitation, at the end of resuscitation and 24 hrs after resuscitation. Data are expressed as mean Ϯ SEM, n Ն 9 in each group. mals in the lung 24 hrs after TH-R, compared with sham-operated animals ( Fig.  5 ). However, neither glucosamine-nor PUGNAc-treated groups showed significant elevation in MPO levels compared with shams. In the heart and in the liver, there were no significant changes in the tissue MPO levels at this time point (data not shown). It should be noted that although increased MPO levels reflect neutrophil accumulation and are an important component in the inflammatory response, it does not on its own indicate an excessive inflammation.
Organ Injury and Apoptosis. Serum levels of alanine transaminase, aspartate transaminase, and lactate dehydrogenase were significantly increased in response to TH-R, although these were signifi-cantly attenuated by PUGNAc, but not glucosamine treatment ( Fig. 6A-C) . Indicators of pancreas (amylase) and kidney (creatinine/blood urea nitrogen) injury did not show significant changes at this time point in any group compared with shams (data not shown). In the liver, there was an almost two-fold increase of apoptosis in the control group compared with the sham group (Fig. 7A) ; however, neither glucosamine nor PUGNAc groups were significantly different from either the sham or control animals. In the lung, there was a ϳ2.8-fold increase in apoptosis in the control group compared with the sham group and this was attenuated in both glucosamine and PUGNAc groups (Fig. 7B ). In the heart, there was no significant change in apoptosis in any group compared with shams (data not shown).
Endoplasmic Reticulum Stress. GRP78 (glucose-regulated protein) is a member of the heat shock protein family and an important indicator of endoplasmic reticulum stress (20) . To evaluate the effects of TH-R and the treatment protocols on emergency room endoplasmic reticulum (ER) stress, we assessed GRP78 levels in the liver because, of those organs studied, the liver seemed to be the most susceptible organ to injury and ER stress. Here we found that there was no significant elevation of GRP78 (Bip) protein in the control or any of treatment groups compared with shams, 24 hrs after TH-R (Fig. 8) , although we cannot rule out the possibility of altered GRP78 levels at an earlier time point.
Protein O-GlcNAc and Phosphorlyation Levels. In the liver, there was a significant (Ͼ50%) decrease in overall O-GlcNAc levels 24 hrs after TH-R, compared with the sham group. PUGNAc treatment resulted in significantly elevated O-GlcNAc levels compared with control animals. However, glucosamine administration did not prevent the loss of O-GlcNAc (Fig. 9A, E) . To demonstrate the specificity of the O-GlcNAc antibody, a duplicate immunoblot was co-incubated with CTD 110.6 antibody and 10 mM N-acetylglucosamine ( Fig. 9B) (21, 22) . Because N-acetylglucosamine acts competitively for specific binding, the lack of signal in Figure 9B indicates that the signal in Figure 9A is due to specific binding of CTD 110.6 antibody.
Furthermore, protein O-GlcNAc levels showed a significant negative correlation with indicators of tissue injury: alanine transaminase (r ϭ Ϫ.71, p Ͻ .05), aspartate transaminase (r ϭ Ϫ.75, p Ͻ .05), lactate dehydrogenase (r ϭ Ϫ.76, p Ͻ .05) and apoptosis (r ϭ Ϫ.63, p Ͻ .05). There was also a modest, but significant correlation between O-GlcNAc levels at 24 hrs and lactate levels (r ϭ Ϫ.54, p Ͻ .05) measured at the end of resuscitation (data not shown).
To determine whether there was a relationship between changes in global O-GlcNAc and phosphorylation levels, we examined both serine and threonine phosphorylation. Phosphorylation of serine residues was significantly elevated in both glucosamine and PUGNAc treated groups compared with controls; in PUG-NAc group, serine phosphorylation was also significantly increased compared with the sham group (Fig. 9C, F) . In contrast, threonine phosphorylation of liver proteins was significantly decreased in the PUGNAc group compared with both control and glucosamine-treated animals ( Fig. 9D, G) .
In the lung, we a found a significant decrease in tissue protein O-GlcNAcylation levels in response to TH-R. Similarly to the liver, it was prevented by PUGNAc, but not glucosamine treatment (Fig.  10A) . The protein O-GlcNAc changes followed a similar pattern in the heart; however, these changes were not significantly different (analysis of variance, p ϭ .07) (Fig. 10B ). of severe injuries occuring with a relatively high incidence (11.4%) and associated with high mortality (61%) (23) . To date, despite the encouraging results of animal experiments, only a few metabolic interventions have been successful in prospective human trials (24) . Here we have demonstrated that enhancing O-GlcNAc levels by either increasing substrate availability with glucosamine or by inhibiting degradation with PUGNAc markedly improved 24-hr survival post severe TH-R in rats. Although both treatments improved survival, only PUGNAc attenuated the hemorrhagic shockinduced proinflammatory responses and end organ injury.
DISCUSSION

Trauma-related multiple organ dysfunction syndrome is a later complication
The mortality rate of our severe trauma-hemorrhage model is comparable with that observed in the "two-hit" model of TH followed by sepsis as well zymosaninduced multiple organ dysfunction syndrome models (19, 25) . Thus, the model described here recapitulates many of the early events associated with multiple organ dysfunction syndrome. Of particular significance, we found that both glucosamine and PUGNAc administration improved survival rates (85% and 86%, respectively) compared with untreated control animals (53%). As the majority of deaths occurred over the first 6 hrs (Fig.  1) , the increased survival and improved blood gas parameters in the treatment groups was most likely a consequence of an early protective effect.
In contrast to the notion of stressinduced hyperglycemia, blood glucose levels were unchanged at the end of hemorrhage and were actually decreased below baseline before resuscitation in control and PUGNAc groups; however, this is most likely due to the fact that all animals were subjected to 24-hr food deprivation before TH-R (5) . Although it is of potential interest that hypoglycemia was not observed in the glucosamine-treated group, it should be noted that this metabolic difference did not seem to influence 24-hr outcome measures. In contrast with the improved survival and early beneficial effects on blood gas parameters in both treatment groups, PUGNAc-but not glucosamine-prevented the majority of proinflammatory responses and attenuated the development of organ injury at the 24-hr time point. As further support for the anti-inflammatory effects of increased O-GlcNAcylation, Xing et al have recently demonstrated that acute glucosamine and PUGNAc treatment reduced inflammatory response in ballooninjured rat carotid arteries (26) . We have also shown at the cellular level that both glucosamine and increased OGT expression significantly attenuated lipopolysaccharide-induced activation of NF-B (27) .
Overall O-GlcNAc levels were markedly decreased in the lung and liver 24 hrs after TH-R, whereas PUGNAc administration resulted in maintained O-GlcNAc levels (Figs. 9 and 10). In our previous studies, O-GlcNAcylation of heart, liver, and kidney showed a marked (Ͼ50%) decrease, 2 hrs after TH-R, and these changes were prevented by PUGNAc administration (11) . Importantly, treatment with the same dose of glucosamine used in this study resulted in significantly higher O-GlcNAc levels at the 2-hr time point, compared with the controls (12, 27) . Notably, O-GlcNAc modification occurs on Ser/Thre residues of proteins, similarly to phosphorylation (1, 8) . Although certain proteins are targeted ex- clusively by O-GlcNAcylation or phosphorylation, they are likely to exist in all possible combinations in a complex cellular environment (9) . In our experiments, in the liver, O-GlcNAcylation levels changed in parallel with serine phosphorylation, but were reciprocal to threonine phosphorylation post TH-R.
Although the loss of O-GlcNAc levels post resuscitation is consistent with our previous studies (1, 8) , it seems to contradict the notion that increased O-GlcNAc formation is a stress-induced response. However, studies have shown that O-GlcNAc levels increase relatively rapidly in response to ischemia and hypoxia, followed by a later decrease during reperfusion (28, 29) . It is also possible that a stress-induced increase in O-GlcNAc levels correlate with cell survival. For example, it has recently been reported that lethal oxidative stress caused time-dependent loss of O-GlcNAc, synchronously with the loss of mitochondrial membrane potential in primary cardiomyocytes (30) . We have previously shown that glucosamine induced in- crease of O-GlcNAcylation correlated with cell survival after ischemia-reperfusion in isolated neonatal cardiac myocytes (29, 31) . In addition, Liu et al have demonstrated a correlation between O-GlcNAc levels and the degree of tissue injury in isolated perfused hearts, after ischemia/reperfusion (32) . In our current study, we found the agonist-induced increase in O-GlcNAc levels negatively correlates with indicators of tissue injury, apoptosis, and serum lactate level after TH-R.
One limitation of this study is that all biochemical parameters were evaluated at a single time point. However, it should be noted that the early beneficial effects of increasing O-GlcNAc levels after TH-R, which included improved cardiac function, decreased inflammatory response and attenuated NF-B signaling, have previously been demonstrated in a comparable TH-R model with the same doses of glucosamine and PUGNAc (11, 12, 27) . It is also important to note that evaluation of tissue myeloperoxidase levels used in this study indicates only increased neutrophil infiltration, and not necessarily excessive inflammation. To demonstrate a direct cause-effect relationship between increased O-GlcNAc levels and survival, the use of transgenic animals could be valuable. However, OGT gene deletion is embryonically lethal (33) , and OGT overexpression induces insulin resistance (34) . Tissue-specific conditional transgenic animals or acute adenoviralmediated enzyme delivery are potential alternative approaches; however, as hypovolemic shock affects all vital organs, it is unclear at this time which tissues or organs should be targeted. Additionally, there is also a possibility for nonspecific effects of PUGNAc, as it has the potential to inhibit lysosomal ␤-hexosaminidases and ␣-N-acetylglucosaminidases in addition to O-GlcNAcase. New, more selective OGT inhibitors (NAG-thiazolines) have been recently synthesized and provide a more specific approach for future studies (35) . However, we have found that PUGNAc and NAG-thiazolines exhibited similar protective effects at the cellular level (31) .
Glucosamine also increases glucosamine-6-phosphate and UDP-GlcNAc levels; consequently its protective effect could be mediated via a number of pathways other than increased O-GlcNAcylation. Glucosamine has also been shown to induce ER stress (36) . This raises the possibility that glucosamine could lead to induction of a cellular stress response that induces a "pre-" or "postconditioning" effect, which leads to protection rather than a consequence of increased O-GlcNAc formation. Therefore, we evaluated GRP78 levels as a marker of ER stress and found that TH-R, glucosamine, or PUGNAc treatment did not have any effect on GRP78 24 hrs after resuscitation. This does not rule out the possibility that the protective effects of glucosamine could be mediated via other pathways, including activation of ER stress response; however, it should be noted that, at the cellular level, both OGT overexpression and glucosamine treatment have similar effects in protecting against ischemia/reperfusion injury and proinflammatory stimuli (27, 31) .
To reduce variability and to ensure consistency with earlier studies, animals were anesthetized and received supplemented oxygen until the end of resuscitation (10, 13) . This is similar to a civilian setting, where anesthesia, oxygen therapy, and temperature control are vital parts of treatment provided in intensive care unit/ER after multiple injury and significant blood loss. However, such in- terventions are not readily available in remote or battlefield settings; consequently, future studies that more closely mimic such conditions may be warranted. Furthermore, consistent with a number of experimental models of hemorrhagic shock and resuscitation, normal saline (NS) was used as the resuscitation fluid (37, 38) , instead of lactated Ringer's solution. However, recent studies have reported that infusion of lactated Ringer's leads to greater hypercoagulability and less hyperchloremic acidosis than NS (39, 40) ; therefore, we cannot rule out the possibility that lactated Ringer's may have improved the outcomes across all TH-R groups compared with NS. In addition, administration of NS in large volumes can also affect the acid-base balance, which could limit the interpretation of blood gas analyses in this study. However, it should be emphasized that the same volume of NS was administered to all groups (except sham-operated animals); therefore, the potential adverse effects resulting from the use of NS will be the same in all TH-R groups. Consequently, we believe it is unlikely that the use of NS as the resuscitation fluid would negate the clinically relevant conclusion of this study-that increasing O-Glc-NAcylation under conditions of severe hypovolemic shock improves survival and decreases tissue injury.
CONCLUSION
This study suggests that interventions designed to increase protein O-GlcNAc levels may represent a valuable novel approach for the treatment of hemorrhagic shock. Furthermore, increasing protein O-GlcNAc levels may also help to prevent the development of systemic inflammatory response syndrome (SIRS) and the resulting multiple organ dysfunction syndrome, decreasing the mortality of severe injuries.
